Literature DB >> 33966737

Changes in anti-müllerian hormone after ultrasound guided aspiration and ethanol sclerotic therapy of ovarian cyst.

Lulu Huang1, Ming-Yang Chang2, Chii-Shin Shiau3, T'sang-T'ang Hsieh4.   

Abstract

OBJECTIVE: To evaluate the effect of transvaginal ultrasound-guided aspiration and ethanol sclerotherapy on anti-müllerian hormone (AMH) in patients with ovarian endometriomas.
SETTING: Teaching hospital affiliated with Chang Gung University, Taipei.
MATERIAL AND METHODS: We retrospectively reviewed 124 patients, with ovarian endometriomas who underwent transvaginal aspiration and sclerotherapy of endometrioma(s) at a tertiary medical center, Chang Gung Memorial Hospital, Taipei, Taiwan. Preoperative evaluation included AMH, midcycle serum CA-125 level, and ultrasonography to exclude possibility of malignancies. Patients underwent ultrasonographic guided transvaginal aspiration and sclerotherapy with 95% ethanol irrigation of the cystic cavity. Patients were grouped into group 1, n = 44, retention of ethanol, and group 2, n = 80, no retention. Serum AMH level was checked at 6 months after aspiration. Those who were infertile prior to therapy were followed up for subsequent pregnancies (either by assisted reproductive technologies, or by natural conception).
RESULTS: The mean pre-operative AMH levels for the group without retention of ethanol and with ethanol retention were 3.80 and 3.06 respectively (p > 0.05). The change in AMH at 6-month follow up for retained group patients was significantly more than for non-retained group patients, with mean decrease of 0.72 (23.6%) and 0.10 (2.7%) respectively (p < 0.05). 54.5% (retained) and 47.2% (non-retained) of patients failed to achieve pregnancy during the observation period.
CONCLUSIONS: Transvaginal aspiration of endometriomas followed by sclerotherapy with ethanol can be effective in preserving ovarian reserve, provided that no ethanol is left in situ.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Anti-müllerian hormone; Endometrioma; Ovarian aspiration; Ovarian reserve; Sclerotherapy

Year:  2021        PMID: 33966737     DOI: 10.1016/j.tjog.2021.03.021

Source DB:  PubMed          Journal:  Taiwan J Obstet Gynecol        ISSN: 1028-4559            Impact factor:   1.705


  2 in total

1.  Efficacy of ablation and sclerotherapy for the management of ovarian endometrioma: A narrative review.

Authors:  Byung Chul Jee
Journal:  Clin Exp Reprod Med       Date:  2022-05-04

2.  Ethanol Sclerotherapy versus Laparoscopic Surgery in Management of Ovarian Endometrioma; a Randomized Clinical Trial.

Authors:  Hatav Ghasemi Tehrani; Raheleh Tavakoli; Maryam Hashemi; Somayeh Haghighat
Journal:  Arch Acad Emerg Med       Date:  2022-07-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.